352 related articles for article (PubMed ID: 31721705)
1.
Vaghefinezhad N; Farsani SF; Gharaghani S
Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705
[TBL] [Abstract][Full Text] [Related]
2. Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells.
Yang L; Zahid M; Liao Y; Rogan EG; Cavalieri EL; Davidson NE; Yager JD; Visvanathan K; Groopman JD; Kensler TW
Carcinogenesis; 2013 Nov; 34(11):2587-92. PubMed ID: 23843041
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives.
Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
Drug Des Devel Ther; 2016; 10():2515-24. PubMed ID: 27540279
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches.
Selvakumar R; Anantha Krishnan D; Ramakrishnan C; Velmurugan D; Gunasekaran K
J Biomol Struct Dyn; 2020 Feb; 38(3):682-696. PubMed ID: 30806580
[TBL] [Abstract][Full Text] [Related]
5. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation.
Raafat A; Mowafy S; Abouseri SM; Fouad MA; Farag NA
Comput Biol Med; 2022 Jul; 146():105526. PubMed ID: 35487125
[TBL] [Abstract][Full Text] [Related]
6. R-sulforaphane modulates the expression profile of AhR, ERα, Nrf2, NQO1, and GSTP in human breast cell lines.
Licznerska B; Szaefer H; Krajka-Kuźniak V
Mol Cell Biochem; 2021 Feb; 476(2):525-533. PubMed ID: 33064289
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation.
Aghagolzadeh P; Radpour R; Bachtler M; van Goor H; Smith ER; Lister A; Odermatt A; Feelisch M; Pasch A
Atherosclerosis; 2017 Oct; 265():78-86. PubMed ID: 28865326
[TBL] [Abstract][Full Text] [Related]
8. A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.
Johnson GS; Li J; Beaver LM; Dashwood WM; Sun D; Rajendran P; Williams DE; Ho E; Dashwood RH
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27860235
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of methysticin and L-sulforaphane through the Nrf2/ARE signaling pathway in MLO-Y4 osteocytes: in vitro study.
Dittmar MC; Tohidnezhad M; Fragoulis A; Bücker A; Stein M; Pufe T; Kubo Y
Ann Anat; 2024 Jun; 254():152260. PubMed ID: 38521364
[TBL] [Abstract][Full Text] [Related]
11. Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms.
Anwar-Mohamed A; Elshenawy OH; Soshilov AA; Denison MS; Chris Le X; Klotz LO; El-Kadi AO
Free Radic Biol Med; 2014 Feb; 67():171-87. PubMed ID: 24161444
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H:quinone oxidoreductase 1 activity reduces hypertrophy in 3T3-L1 adipocytes.
Vomhof-DeKrey EE; Picklo MJ
Free Radic Biol Med; 2012 Aug; 53(4):690-700. PubMed ID: 22683604
[TBL] [Abstract][Full Text] [Related]
13. Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway.
Petkovic M; Leal EC; Alves I; Bose C; Palade PT; Singh P; Awasthi S; Børsheim E; Dalgaard LT; Singh SP; Carvalho E
J Nutr Biochem; 2021 Dec; 98():108817. PubMed ID: 34271100
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane ameliorates serum starvation-induced muscle atrophy via activation of the Nrf2 pathway in cultured C2C12 cells.
Moon JY; Kim DJ; Kim HS
Cell Biol Int; 2020 Sep; 44(9):1831-1839. PubMed ID: 32401383
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides.
Ghorab MM; Higgins M; Alsaid MS; Arafa RK; Shahat AA; Dinkova-Kostova AT
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):840-5. PubMed ID: 24417210
[TBL] [Abstract][Full Text] [Related]
17. Combined molecular modelling and 3D-QSAR study for understanding the inhibition of NQO1 by heterocyclic quinone derivatives.
López-Lira C; Alzate-Morales JH; Paulino M; Mella-Raipán J; Salas CO; Tapia RA; Soto-Delgado J
Chem Biol Drug Des; 2018 Jan; 91(1):29-38. PubMed ID: 28643389
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways.
Jang M; Cho IH
Mol Neurobiol; 2016 May; 53(4):2619-35. PubMed ID: 26096705
[TBL] [Abstract][Full Text] [Related]
19. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage.
Gao X; Talalay P
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10446-51. PubMed ID: 15229324
[TBL] [Abstract][Full Text] [Related]
20. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
